CPT® Code 86485

1. Indications

The candida skin test is indicated for use in specific clinical scenarios where assessing the immune response is critical. The following conditions warrant the performance of this test:

• Compromised Cellular Immunity The test is performed in patients who may have a compromised immune system, which can lead to inaccurate results in other skin tests, such as the tuberculin skin test.
• Evaluation of Delayed Type Hypersensitivity It is utilized to evaluate delayed type hypersensitivity responses, particularly in the context of tuberculosis screening.
• False Negative Tuberculin Test The test is indicated when a patient has a negative reaction to a PPD skin test, and there is a need to determine if the negative result is due to anergy.

2. Procedure

The procedure for administering the candida skin test involves several key steps to ensure accurate results and patient safety. The following outlines the procedural steps:

• Step 1: Preparation The healthcare provider prepares the necessary materials, including the candida antigen, syringes, and alcohol swabs. The patient’s medical history is reviewed to confirm the indication for the test and to check for any contraindications.
• Step 2: Administration The candida antigen is injected intradermally, typically on the forearm. The injection site is cleansed with an alcohol swab prior to administration to minimize the risk of infection.
• Step 3: Observation After the injection, the patient is instructed to return for evaluation of the test results, usually within 48 to 72 hours. The healthcare provider will assess the injection site for any signs of a reaction.
• Step 4: Interpretation The results are interpreted based on the size of the induration at the injection site. A positive reaction indicates a functioning immune response, while a negative reaction may suggest an impaired immune system.

3. Post-Procedure

Post-procedure care for the candida skin test is minimal but important for ensuring patient comfort and accurate interpretation of results. Patients are advised to keep the injection site clean and dry, avoiding any topical applications that could interfere with the test results. They should also be informed about potential reactions, such as redness or swelling at the injection site, which are common and typically resolve without intervention. Patients are encouraged to return to the healthcare provider for evaluation of the test results within the specified timeframe, as timely assessment is crucial for accurate diagnosis and management of any underlying conditions.